SCHEMBL6613017

SCHEMBL6613017

COc1cc(-c2cc(=O)c3ccc(O)c(O)c3o2)ccc1O

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TERT O14746 6/20 0.88
▸ CSNK2A2 P19784 9/20 0.76
▸ CSNK2B P67870 9/20 0.76
▸ CSNK2A1 P68400 9/20 0.76
▸ BRD4 O60885 1/20 0.71
▸ KDM4E B2RXH2 2/20 0.66
▸ MEN1 O00255 2/20 0.66
▸ POLB P06746 2/20 0.66
▸ MAPT P10636 2/20 0.66
▸ KMT2A Q03164 2/20 0.66
▸ ALDH1A1 P00352 1/20 0.66
▸ GAA P10253 1/20 0.66
▸ RECQL P46063 1/20 0.66
▸ L3MBTL1 Q9Y468 1/20 0.66
▸ CYP3A4 P08684 1/20 0.65
▸ CYP2D6 P10635 1/20 0.65
▸ CYP2C9 P11712 1/20 0.65
▸ HPGD P15428 1/20 0.65
▸ MAPK1 P28482 1/20 0.65
▸ CYP2C19 P33261 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6612829 0.94 TERT (0.86) TERTCSNK2A2CSNK2BCSNK2A1KDM4E
SCHEMBL1778286 0.94 TERT (1.00) TERTCSNK2A2CSNK2BCSNK2A1BRD4
SCHEMBL6614126 0.91 TERT (1.00) TERTCSNK2A2CSNK2BCSNK2A1BRD4
SCHEMBL6613428 0.91 TERT (0.81) TERTCSNK2A2CSNK2BCSNK2A1BRD4
SCHEMBL6802044 0.88 TERT (0.77) TERTCSNK2A2CSNK2BCSNK2A1BRD4
SCHEMBL7377070 0.88 CSNK2A2 (0.86) TERTCSNK2A2CSNK2BCSNK2A1KDM4E
SCHEMBL6617685 0.88 CSNK2A2 (0.74) TERTCSNK2A2CSNK2BCSNK2A1KDM4E
SCHEMBL6613454 0.86 TERT (1.00) TERTCSNK2A2CSNK2BCSNK2A1BRD4
SCHEMBL6614508 0.85 TERT (0.73) TERTCSNK2A2CSNK2BCSNK2A1BRD4
SCHEMBL7377434 0.85 CSNK2A2 (0.69) TERTCSNK2A2CSNK2BCSNK2A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2004-04-01 — — US claimed
EP-1373244-A2 SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-01-02 — — EP claimed
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2002-10-31 — — US claimed
WO-2002074036-A2 SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2002-09-26 — — WO claimed
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2004-04-01 — — US disclosed
EP-1373244-A2 SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-01-02 — — EP disclosed
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2002-10-31 — — US disclosed
WO-2002074036-A2 SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2002-09-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP TERT 1/4885CSNK2A2 682/4885CSNK2B 593/4885
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP TERT 1/4885CSNK2A2 687/4885CSNK2B 605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback